Gossamer Bio (GOSS) Operating Leases (2019 - 2026)
Gossamer Bio's Operating Leases was $2.96 million in Q2 2026, down 24.8% from $3.93 million a year earlier and down 7.9% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Gossamer Bio came in at $3.46 million, down 21.3% from FY2024.
- Operating Leases shows a five-year compound annual growth rate of -14.8% (FY2020 to FY2025).
- In earlier years, Operating Leases was $4.4 million in FY2024, $144,000 in FY2023 (-95.8%), $3.45 million in FY2022 (+7.1%) and $3.22 million in FY2021 (-58.3%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q4 2023.
- Compared with a year earlier, Operating Leases has declined for four straight quarters, with growth averaging 54.9% over the last five quarters.
- The best year-over-year quarter for Operating Leases over five years was Q3 2024 (growth of 363.0%); the worst was Q4 2023 (a decline of 95.8%).
- Per Business Quant data, GOSS's Operating Leases in the three quarters before Q2 2026 was $3.21 million (Q1 2026), $3.46 million (Q4 2025) and $3.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.80 Bn | 1,100.39 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 614.01 Bn | 532.53 Bn | 17.26 Bn |
| 3 | AbbVie | 503.59 Bn | 476.70 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.81 Bn | 261.80 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.50 Bn | 235.19 Bn | 12.86 Bn |
| 7 | Amgen | 236.24 Bn | 191.64 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn |
| 10 | Gossamer Bio | 41.00 Mn | -432.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 3.93 Mn |
| Mar 31, 2025 | 4.17 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Dec 31, 2023 | 144,000.00 |
| Sep 30, 2023 | 992,000.00 |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 4.21 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 5.71 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.96 Mn |
| Jun 30, 2021 | 6.17 Mn |
| Mar 31, 2021 | 6.95 Mn |
API Access
Gossamer Bio Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();